Clinical Trial

Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer

Name: Long-Term Survival With Lenvatinib-Based Therapy in Unresectable Liver Cancer — clinical trial record (NCT07298538)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

This study reviewed real-world outcomes of patients with unresectable hepatocellular carcinoma who received lenvatinib-based treatment. The study evaluated long-term survival, treatment response, and safety using data collected from six hospitals.

Trial Details

NCT Number	NCT07298538
Lead Sponsor	Tianjin Medical University Cancer Institute and Hospital
Conditions	Unresectable Hepatocellular Carcinoma
Enrollment	800 participants
Start Date	2019-01-01
Primary Completion	2025-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2025-12-23